Inceptua Early Access and Sentynl Therapeutics Inc. announce the launch of the Early Access Program for Nulibry®
October 11, 2022
October 11, 2022
September 27, 2022
September 21, 2022
September 20, 2022
September 20, 2022
September 8, 2022
August 30, 2022
July 7, 2022
June 16, 2022
December 16, 2024
BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted ...
December 11, 2024
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to...
December 10, 2024
Innovative Cell Expansion System Enables Real-Time Metabolic Monitoring and Automated Culture Optimization to Accelerate Cell and Gene Therapy Manufac...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225